Huang Haohai, Zou Ying, Chi Honggang
Drug design, development and therapy, 2018
Abstract
Background
Chitosan is a popular dietary fiber often used to reduce dietary fat absorption to control weight and blood lipids. However, its effects on blood pressure (BP) have not been fully elucidated. We evaluated the effects of chitosan administration on systolic blood pressure (SBP) and diastolic blood pressure (DBP) through a pooled analysis of available randomized controlled trials (RCTs).
Materials and Methods
Electronic searches were conducted in Medline, Cochrane Library, Scopus, and EMBASE to identify relevant human placebo-control RCTs. Trials that reported BP changes from baseline to study endpoint in patients receiving treatment of chitosan were included for analysis. Weighted mean difference (WMD) and 95% CIs were pooled using fixed-effects or random-effects models. Statistical heterogeneity, prespecified subgroup, publication bias, sensitivity analysis, and meta-regression assessments were also tested.
Results
Six hundred and seventeen participants from eight trials with 10 arms were included. Overall, chitosan administration did not significantly lower SBP (WMD: -1.41 mmHg, 95% CI: -3.29 to 0.47; P=0.14) and DBP (WMD: -0.61 mmHg, 95% CI: -1.75 to 0.52; P=0.29). However, our subgroup analyses indicated that chitosan consumption significantly reduced DBP in shorter-term (<12 weeks) and higher-dose (>2.4 g/day) arms. Funnel plots or Egger's tests analysis (P=0.36 and 0.43 for SBP and DBP, respectively) demonstrated that there was no significant publication bias in this study.
Conclusion
This meta-analysis indicates that chitosan consumption significantly decreases DBP at higher dosage and in shorter-term interventions, while chitosan has no significant effects on SBP. However, these results should be interpreted cautiously because of the limited eligible RCTs included in this meta-analysis; further large-scale, well-designed RCTs on this topic are urgently needed.
Keywords
blood pressure; chitosan; hypertension; meta-analysis
| PMID: | 29343944 |
|---|---|
| Category: | General properties of Chitosan |
Articles similar to "Quantitative assessment of the effects of chitosan intervention on blood pressure control."
- The properties of Chitosan: Chitosan as a starting material for wound healing applications. (Chitosan and its derivatives have attracted great attention due to their properties beneficial for application to wound healing...)
- The properties of Chitosan: The potential of chitosan and its derivatives in prevention and treatment of age-related diseases. (Age-related, diet-related and protein conformational diseases, such as atherosclerosis, diabetes mellitus, cancer, hypercholesterolemia, cardiovascular and neurodegenerative diseases are common in the elderly population...)
- The properties of Chitosan: Chitosan as potential marine nutraceutical. (Chitosan, the most abundant marine mucopolysaccharide, is derived from chitin by alkaline deacetylation, and possesses versatile biological properties such as biocompatibility, biodegradability, and a non-toxic nature...)
- The properties of Chitosan: Recent patents on food applications of chitosan. (Chitosan is a natural polysaccharide that has become of great interest due to its multiple possible applications, which is a great challenge for both the scientific community and the food industry...)
- The properties of Chitosan: The safety of chitosan as a pharmaceutical excipient. (Interest in use of the polysaccharide chitosan as a pharmaceutical excipient by different dose routes and for a number of applications is not new but it still does not appear to be present in any marketed drugs...)
Previous article
Chitosan as a starting material for wound healing applications.
Next article
Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction.